Literature DB >> 28797501

Integrating Morphology and Genetics in the Diagnosis of Cartilage Tumors.

Carlos E de Andrea1, Mikel San-Julian2, Judith V M G Bovée3.   

Abstract

Cartilage-forming tumors of bone are a heterogeneous group of tumors with different molecular mechanisms involved. Enchondromas are benign hyaline cartilage-forming tumors of medullary bone caused by mutations in IDH1 or IDH2. Osteochondromas are benign cartilage-capped bony projections at the surface of bone. IDH mutations are also found in dedifferentiated and periosteal chondrosarcoma. A recurrent HEY1-NCOA2 fusion characterizes mesenchymal chondrosarcoma. Molecular changes are increasingly used to improve diagnostic accuracy in chondrosarcomas. Detection of IDH mutations or HEY1-NCOA2 fusions has already proved their immense value, especially on small biopsy specimens or in case of unusual presentation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cartilaginous tumors; Chondrosarcoma; Enchondroma; HEY1-NCOA2 fusion; IDH mutations; Osteochondroma

Mesh:

Year:  2017        PMID: 28797501     DOI: 10.1016/j.path.2017.04.005

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  8 in total

Review 1.  Bone and soft tissue tumors at the borderlands of malignancy.

Authors:  Julia Crim; Lester J Layfield
Journal:  Skeletal Radiol       Date:  2022-06-29       Impact factor: 2.199

2.  Quantitative Chemical Imaging of Bone Tissue for Intraoperative and Diagnostic Applications.

Authors:  Kseniya S Shin; Shuaiqian Men; Angel Wong; Colburn Cobb-Bruno; Eleanor Y Chen; Dan Fu
Journal:  Anal Chem       Date:  2022-02-21       Impact factor: 6.986

3.  Translocase of the outer mitochondrial membrane complex subunit 20 (TOMM20) facilitates cancer aggressiveness and therapeutic resistance in chondrosarcoma.

Authors:  Megan E Roche; Zhao Lin; Diana Whitaker-Menezes; Tingting Zhan; Karoly Szuhai; Judith V M G Bovee; John A Abraham; Wei Jiang; Ubaldo Martinez-Outschoorn; Atrayee Basu-Mallick
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-10       Impact factor: 5.187

4.  Intracranial Mesenchymal Chondrosarcoma Lacking the Typical Histopathological Features Diagnosed by HEY1-NCOA2 Gene Fusion.

Authors:  Atsuhito Uneda; Kazuhiko Kurozumi; Atsushi Fujimura; Atsunori Kamiya; Takanori Hirose; Hiroyuki Yanai; Isao Date
Journal:  NMC Case Rep J       Date:  2020-03-24

Review 5.  Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.

Authors:  Sanne Venneker; Karoly Szuhai; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2019-11-14       Impact factor: 4.064

Review 6.  Benign Bone Tumors: An Overview of What We Know Today.

Authors:  Sara De Salvo; Vito Pavone; Sebastiano Coco; Eleonora Dell'Agli; Chiara Blatti; Gianluca Testa
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

7.  Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.

Authors:  Wenqing Qi; Wojciech Rosikiewicz; Zhaohong Yin; Beisi Xu; Huihong Jiang; Shibiao Wan; Yiping Fan; Gang Wu; Lu Wang
Journal:  J Pathol       Date:  2022-04-26       Impact factor: 9.883

8.  Chondromesenchymal hamartomas in a 24-year-old male mimicking a posterior mediastinal tumor and a 5-month-old boy with postoperative disseminated intravascular coagulation: two case reports.

Authors:  Yue Li; Danyang Zheng; Min Zuo; Yang Li; Huizhong Zhang
Journal:  Diagn Pathol       Date:  2020-05-12       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.